Teoh M, Narayanan P, Moo KS, Radhakrisman S, Pillappan R, Bukhari NI, Segarra I
Imatinib inhibits Bcr-Abl, c-KIT and PDGFR kinases. It is approved for the treatment of chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GIST) and has further therapeutic potential